Dermorphin Vial

Dermorphin is a naturally derived heptapeptide originally isolated from South American Phyllomedusa frog species. It is commonly utilised in laboratory research involving peptide–receptor interactions and opioid receptor–related signalling pathways. The peptide contains a D-amino acid (D-Ala) within its structure, which contributes to its structural properties in controlled experimental settings.

Chemical reference information: CAS number: 77614-16-5; Molecular formula: C₄₀H₅₀N₈O₁₀; Molecular weight: 802.88 g/mol; Sequence: Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

Dermorphin 5 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CAS number

77614-16-5

Molecular formula

C₄₀H₅₀N₈O₁₀

Molecular weight

802.88 g/mol

Sequence

Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.